CIK 0001094038
- Non-accelerated filer
- Smaller reporting company
Marker Therapeutics, Inc.
Sign in to watch- Ticker
- MRKR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 880277072
- Phone
- +1 713-400-6400
- Business address
- 2450 HOLCOMBE BLVD, TMC PARTNERS OFFICE 1.311, HOUSTON, TX, 77021
- Former names
- TAPIMMUNE INC., TAPIMMUNE INC, GENEMAX CORP, EDUVERSE COM
- DEF 14A Proxy Proxy Statement
- 8-K Event Executive or director change
- 8-K Event Material agreement · Unregistered share sale
- 8-K Event Material agreement · Other events
- 8-K Event Other events
- 8-K Event Results of operations
- 8-K Event Results of operations
- 8-K Event Other events
- 8-K Event Shareholder vote results · Other events
- 8-K Event Results of operations
- DEF 14A Proxy Proxy Statement
- 8-K Event Other events
- 8-K Event Results of operations
- 10-K Report Annual Report
- 8-K Event Agreement ended
- 8-K Event Material agreement
- 8-K Event Regulation FD disclosure
- 8-K Event Other events
- 8-K Event Executive or director change
- 8-K Event Results of operations
Page 2 of 13 · 245 filings